Stimulation of Cl- secretion by chlorzoxazone

Journal of Pharmacology and Experimental Therapeutics

Volumn 292, Issue 2, 2000, Pages 778-787

  Singh, Ashvani K ^a,b   Devor, Daniel C ^a   Gerlach, Aaron C ^a   Gondor, Margaret ^a   Pilewski, Joseph M ^a   Bridges, Robert J ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHARYBDOTOXIN; CHLORZOXAZONE; GLIBENCLAMIDE; IMIDAZOLINE DERIVATIVE; NYSTATIN; POTASSIUM CHANNEL; TRANSMEMBRANE CONDUCTANCE REGULATOR; ZOXAZOLAMINE;

ARTICLE; BASOLATERAL MEMBRANE; CHLORIDE CURRENT; CHLORIDE TRANSPORT; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DRUG EFFECT; DRUG MECHANISM; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; MALE; MEMBRANE VESICLE; PRIORITY JOURNAL;

AMILORIDE; ANIONS; BRONCHI; BUMETANIDE; CELL MEMBRANE; CELLS, CULTURED; CHARYBDOTOXIN; CHLORINE; CHLORZOXAZONE; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DRUG INTERACTIONS; EPITHELIUM; FORSKOLIN; GLYBURIDE; HUMANS; ISOPROTERENOL; NASAL MUCOSA; NYSTATIN; POTASSIUM CHANNEL BLOCKERS; RUBIDIUM; ZOXAZOLAMINE;

EID: 0033980791     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Boat TF and Cheng PW (1989) Epithelial cell dysfunction in cystic fibrosis: Implications for airways disease. Acta Paediatr Scand Suppl 363:25-29.
2. + uptake into colonic enterocyte membrane vesicles. Am J Physiol 254:C484-C490.
3. Champigny G, Imler JL, Puchelle E, Dalemans W, Gribkoff V, Hinnrasky J, Dott K, Barbry P, Pavirani A and Lazdunski M (1995) A change in gating mode leading to increased intrinsic Cl-channel activity compensates for defective processing in a cystic fibrosis mutant corresponding to a mild firm of the disease. EMBO J 14:2417-2423.
4. - channels in primary cultures of spiny dogfish (Squalus acanthias) rectal gland. Am J Physiol 268:C70-C79.
5. + channel in colonic secretory cells. Am J Physiol 265:C1271-C1280.
6. K. Am J Physiol 271:L785-L795.
7. - secretion. Am J Physiol 272:C976-C988.
8. + channel. Am J Physiol 271:L775-L784.
9. + channels. Am J Physiol 273:C531-C540.
10. Devor DC, Singh AK, Lambert LC, DeLuca A, Frizzell RA and Bridges RJ (1999) Bicarbonate and chloride secretion in Calu-3 human airway epithelial cells. J Gen Physiol 113:743-760.
11. Elenbaas JK (1980) Centrally acting oral skeleton muscle relaxants. Am J Hosp Pharm 37:1313-1323.
12. Galvez A, Gimenez-Gallego G, Reuben JP, Roy-Contancin L, Feigenbaum P, Kaczorowski GJ and Garcia MLJ (1990) Purification and characterization of a unique, potent, peptidyl probe for the high conductance calcium-activated potassium channel from venom of the scorpion Buthus tamalus. J Biol Chem 265:11083-11090.
13. Garty H, Rudy B and Karlish SJD (1983) A simple and sensitive procedure for measuring isotope fluxes through ion-specific channels in heterogeneous populations of membrane vesicles. J Biol Chem 258:13094-13099.
14. Gasko OD, Knowles AF, Shertzor HG, Soulina EM and Racker E (1976) The use of ion-exchange resins for studying ion transport in biological systems. Anal Biochem 72:57-65.
15. Gribkoff VK, Chaampigny G, Barbry P, Dworetzky SI, Meanwell NA and Lazdunski M (1994) The substituted benzimidazolone NS004 is an opener of the cystic fibrosis chloride channel. J Biol Chem 269:10983-10986.
16. Knaus H-G, McManus OB, Lee SH, Schmalhofer WA, Garcia-Calvo M, Helms LMH, Sanchez M, Giangiacomo K, Reuben JP, Smith AB III, Kaczorowski GJ and Garcia ML (1994) Tremorgenic indole alkaloids potently inhibit smooth muscle high-conductance calcium-activated potassium channels. Biochemistry 33:5819-5828.
17. Knowles MR, Clarke LL and Boucher RC (1991) Activation by extracellular nucleotides of chloride secretion in the airway epithelia of patients with cystic fibrosis. N Engl J Med 325:533-538.
18. Knowles MR, Clarke LL and Boucher RC (1992) Extracellular ATP and UTP induce chloride secretion in nasal epithelia of cystic fibrosis patients and normal subjects in vivo. Chest 101 (3 Suppl):60S-63S.
19. Mason SJ, Paradiso AM and Boucher RC (1991) Regulation of transepithelial ion transport and intracellular calcium by extracellular ATP in human normal and cystic fibrosis airway epithelium. Br J Pharmacol 103:1649-1656.
20. McKay MC, Dworetzky SI, Meanwell NA, Olesen S-P, Reinhart PH, Levitan IB, Adelman JP and Gribkoff VK (1994) Opening of large-conductance calcium-activated potassium channels by the substituted benzimidazolone NS004. J Neurophysiol 71:1873-1882.
21. +-channels by novel benzimidazolone. Eur J Pharmacol 251:53-59.
22. Physicians' Desk Reference (1996) Parafon Forte DSC, in Physicians' Desk Reference, Medical Economics Co., Inc., Montvale, New Jersey.
23. Pilewski J and Frizzell RA (1999) Role of CFTR in airway disease. Physiol Rev 79:S215-S255.
24. Schultz BD, Bridges RJ and Frizzell RA (1999) Rescue of dysfunctional ΔF508-CFTR chloride channel activity by IBMX. J Memb Biol 170:51-66.
25. Schultz BD, DeRoos ADG, Venglarik CJ, Singh AK, Frizzell RA and Bridges RJ (1996) Glibenclamide blockade of CFTR chloride channels. Am J Physiol 271: L192-L200.
26. Schultz BD, Singh AK, Devor DC and Bridges RJ (1999a) Pharmacology of CFTR chloride channel activity. Pharmacol Rev 79:S109-S144.
27. Sellers AJ and Ashford MLJ (1994) Activation of Bcc channels in acutely dissociated neurons from the rat ventromedial hypothalamus by NS1619. Br J Pharmacol 113:659-661.
28. + channel regulators on cystic fibrosis transmembrane conductance regulator chloride currents. J Gen Physiol 100:573-591.
29. Stewart JT and Janaki CA (1987) Chlorzoxazone. Anal Profiles Drug Subst 16:119-144.
30. Strong TV, Smit LS, Nasr S, Wood DL, Cole JL, Iannuzzi MC, Stern RC and Collins FS (1992) Characterization of an intron 12 splice donor mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Hum Mutat 1:380-387.
31. Welsh MJ and Smith AE (1993) Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell 73:1251-1254.
32. K explore calcium's role. J Gen Physiol 96:1271-1285.
33. Zeitlin PL (1998) Therapies directed at the basic defect in cystic fibrosis. Clin Chest Med 19:515-525.